Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
Bo Lian,1,* Hua Wei,2,* Ruiyan Pan,3,* Jingui Sun,4 Bo Zhang,3 Jingliang Wu,1 Xiujie Li,1 Guixiang Tian1 1School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of China; 2Department of Endocrinology, ShouGuang Peoples’ Hospital, Weifan...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-01-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/galactose-modified-liposomes-for-effective-co-delivery-of-doxorubicin--peer-reviewed-article-IJN |
| _version_ | 1818995288613847040 |
|---|---|
| author | Lian B Wei H Pan R Sun J Zhang B Wu J Li X Tian G |
| author_facet | Lian B Wei H Pan R Sun J Zhang B Wu J Li X Tian G |
| author_sort | Lian B |
| collection | DOAJ |
| description | Bo Lian,1,* Hua Wei,2,* Ruiyan Pan,3,* Jingui Sun,4 Bo Zhang,3 Jingliang Wu,1 Xiujie Li,1 Guixiang Tian1 1School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of China; 2Department of Endocrinology, ShouGuang Peoples’ Hospital, Weifang 262700, People’s Republic of China; 3School of Pharmacy, Weifang Medical University, Weifang 261053, People’s Republic of China; 4Department of Oncology, ShouGuang Peoples’ Hospital, Weifang 262700, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiujie Li Email lixiujie@wfmc.edu.cnGuixiang TianSchool of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of ChinaEmail gxtian2008@163.comBackground: Tumor angiogenesis plays a crucial role in tumor development, and recent efforts have been focused on combining proapoptotic and antiangiogenic activities to enhance antitumor therapy.Methods: In this study, galactose-modified liposomes (Gal-LPs) were prepared for co-delivery of doxorubicin (DOX) and combretastatin A4 phosphate (CA4P). The co-cultured system composed of BEL-7402 and human umbilical vein endothelial cells (HUVEC) cells was established to effectively evaluate in vitro anti-tumor activity through cell viability and cell migration assay. Furthermore, both in vivo bio-distribution and anti-hepatoma effect of DOX&CA4P/Gal-LPs were investigated on H22 tumor cell-bearing mice.Results: The results showed that DOX&CA4P/Gal-LPs were spherical with a mean particle size of 143 nm, and could readily be taken up by BEL-7402 cells. Compared with a mixture of free DOX and CA4P, the DOX&CA4P/Gal-LPs were more effective in inhibiting cell migration and exhibited stronger cytotoxicity against BEL-7402 cells alone or a co-cultured system. The in vitro studies showed that the co-cultured system was a more effective model to evaluate the anti-tumor activity of combination therapy. Moreover, DOX&CA4P/Gal-LPs exhibited a greater anti-hepatoma effect than other drug formulations, indicating that Gal-LPs could promote drug accumulation in the tumor region and improve the anti-tumor activity.Conclusion: Gal-LPs co-loaded with chemotherapeutic and antiangiogenic drugs are a promising strategy for anti-hepatoma therapy.Keywords: liposomes, anti-hepatoma, co-delivery, combination therapy |
| first_indexed | 2024-12-20T21:11:28Z |
| format | Article |
| id | doaj.art-dbe24a1382ae4d4e884d8385cc661d6e |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-12-20T21:11:28Z |
| publishDate | 2021-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-dbe24a1382ae4d4e884d8385cc661d6e2022-12-21T19:26:30ZengDove Medical PressInternational Journal of Nanomedicine1178-20132021-01-01Volume 1645746761241Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4Lian BWei HPan RSun JZhang BWu JLi XTian GBo Lian,1,* Hua Wei,2,* Ruiyan Pan,3,* Jingui Sun,4 Bo Zhang,3 Jingliang Wu,1 Xiujie Li,1 Guixiang Tian1 1School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of China; 2Department of Endocrinology, ShouGuang Peoples’ Hospital, Weifang 262700, People’s Republic of China; 3School of Pharmacy, Weifang Medical University, Weifang 261053, People’s Republic of China; 4Department of Oncology, ShouGuang Peoples’ Hospital, Weifang 262700, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiujie Li Email lixiujie@wfmc.edu.cnGuixiang TianSchool of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of ChinaEmail gxtian2008@163.comBackground: Tumor angiogenesis plays a crucial role in tumor development, and recent efforts have been focused on combining proapoptotic and antiangiogenic activities to enhance antitumor therapy.Methods: In this study, galactose-modified liposomes (Gal-LPs) were prepared for co-delivery of doxorubicin (DOX) and combretastatin A4 phosphate (CA4P). The co-cultured system composed of BEL-7402 and human umbilical vein endothelial cells (HUVEC) cells was established to effectively evaluate in vitro anti-tumor activity through cell viability and cell migration assay. Furthermore, both in vivo bio-distribution and anti-hepatoma effect of DOX&CA4P/Gal-LPs were investigated on H22 tumor cell-bearing mice.Results: The results showed that DOX&CA4P/Gal-LPs were spherical with a mean particle size of 143 nm, and could readily be taken up by BEL-7402 cells. Compared with a mixture of free DOX and CA4P, the DOX&CA4P/Gal-LPs were more effective in inhibiting cell migration and exhibited stronger cytotoxicity against BEL-7402 cells alone or a co-cultured system. The in vitro studies showed that the co-cultured system was a more effective model to evaluate the anti-tumor activity of combination therapy. Moreover, DOX&CA4P/Gal-LPs exhibited a greater anti-hepatoma effect than other drug formulations, indicating that Gal-LPs could promote drug accumulation in the tumor region and improve the anti-tumor activity.Conclusion: Gal-LPs co-loaded with chemotherapeutic and antiangiogenic drugs are a promising strategy for anti-hepatoma therapy.Keywords: liposomes, anti-hepatoma, co-delivery, combination therapyhttps://www.dovepress.com/galactose-modified-liposomes-for-effective-co-delivery-of-doxorubicin--peer-reviewed-article-IJNliposomesanti-hepatomaco-deliverycombination therapy |
| spellingShingle | Lian B Wei H Pan R Sun J Zhang B Wu J Li X Tian G Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 International Journal of Nanomedicine liposomes anti-hepatoma co-delivery combination therapy |
| title | Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 |
| title_full | Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 |
| title_fullStr | Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 |
| title_full_unstemmed | Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 |
| title_short | Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4 |
| title_sort | galactose modified liposomes for effective co delivery of doxorubicin and combretastatin a4 |
| topic | liposomes anti-hepatoma co-delivery combination therapy |
| url | https://www.dovepress.com/galactose-modified-liposomes-for-effective-co-delivery-of-doxorubicin--peer-reviewed-article-IJN |
| work_keys_str_mv | AT lianb galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT weih galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT panr galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT sunj galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT zhangb galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT wuj galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT lix galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 AT tiang galactosemodifiedliposomesforeffectivecodeliveryofdoxorubicinandcombretastatina4 |